Here is what the editors at Physician’s Briefing chose as the most important COVID-19 developments for you and your practice for the week of June 1 to 4, 2021. This […]
Here is what the editors at Physician’s Briefing chose as the most important COVID-19 developments for you and your practice for the week of June 1 to 4, 2021. This roundup includes the latest research news from journal studies and other trusted sources that is most likely to affect clinical practice.
Decline in Births Linked to COVID-19 Pandemic Societal Shutdown
FRIDAY, June 4, 2021 (HealthDay News) — There was an initial decline in births in association with the COVID-19 pandemic societal lockdown, but a birth volume surge is anticipated in summer 2021, according to a study published online June 3 in JAMA Internal Medicine.
SARS-CoV-2 RNAemia Infrequent in Blood Donors
THURSDAY, June 3, 2021 (HealthDay News) — Nucleic acid testing of donor plasma minipools indicates that severe acute respiratory syndrome coronavirus 2 RNAemia is infrequent, according to a study published online May 27 in Transfusion.
NIH Starts Trial Assessing ‘Mix & Match’ COVID-19 Vaccine Approach
WEDNESDAY, June 2, 2021 (HealthDay News) — There is a new clinical trial underway to assess the safety and effectiveness of mixing different types of booster shots in adults who have been fully vaccinated against COVID-19.
BNT162b2 Vaccine Safe, Effective for Teens Aged 12 to 15 Years
WEDNESDAY, June 2, 2021 (HealthDay News) — The BNT162b2 COVID-19 vaccine is safe and effective for adolescents aged 12 to 15 years, according to a study published online May 27 in the New England Journal of Medicine.
Most Severe Effects of PIMS-TS Resolved at Six Months
WENESDAY, June 2, 2021 (HealthDay News) — Though the need for physical rehabilitation and mental health concerns persist, organ-specific sequelae of pediatric inflammatory multisystem syndrome temporally associated with severe acute respiratory syndrome coronavirus 2 appear to be resolved at six months, according to a study published online May 24 in The Lancet Child and Adolescent Health.
ASCO: COVID-19 Infections, Deaths Not Up With Breast Cancer Chemo
WEDNESDAY, June 2, 2021 (HealthDay News) — Patients receiving chemotherapy for breast cancer do not have an increased risk for severe acute respiratory syndrome coronavirus 2 infection or mortality, according to a study scheduled to be presented at the annual meeting of the American Society of Clinical Oncology, held virtually from June 4 to 8.
Drug-Induced Immunosuppression Examined in U.S. Adults
WEDNESDAY, June 2, 2021 (HealthDay News) — Overall, 2.8 percent of a national cohort of commercially insured U.S. adults meet criteria for drug-induced immunosuppression, of whom 67.7 percent receive oral corticosteroids, according to a research letter published online May 20 in JAMA Network Open.
WHO Approves Second Chinese COVID-19 Vaccine
AAP Issues Recommendations for Pediatric RSV Vaccination in 2026-2027 Season 
Trends Reported in Vaccination Coverage for Adolescents for 2025 
2005 to 2023 Saw More U.S. Women Never Screened for Cervical Cancer 
4CMenB Vaccine Confers Modest Protection Against Gonorrhea in Teens 
Social Media Warnings Could Discourage Use Among Teens, Young Adults 
Digital Behavioral Health Game Reduces Depressive Symptoms in Teens .jpeg)
Flu Treatment With Oseltamivir Linked to Reduced Risk for Pediatric ICU Admissions, Length of Stay 
Reinitiating Obesity Meds After Bariatric Surgery Tied to Greater One-Year Weight Loss in Youths 
